Goal setting and attainment pertaining to upper and lower limb function in post-stroke spasticity (PSS) patients: The Botox® Economic Spasticity Trial (BEST)  by Ward, A. et al.
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xcitability was studied by collecting responses H, M and T, and the stiffness of
he ankle in passive conditions measured by applying sinusoidal perturbations.
esults.– Spastic equinovarus foot is associated with reflex hyperexcitability
ratios Hmax/Mmax average: 0.73; and T/Mmax: 0.66) related to central hyper-
xcitability plus hyper solicitation of muscle receptors to stretching related to
he increased stiffness of visco elastic structures of the ankle (ankle passive
tiffness measured average at 64 Nm/rad). This increase in passive stiffness
s most probably linked with changes in elastic properties of spastic muscle
nd also with increased muscle rest tone by increasing the number of resi-
ual actin-myosin bridges. Lidocaine block causes a clinical improvement of all
arameters associated with a decrease in reflex excitability (ratios Hmax/Mmax
verage: 0.24; and T/Mmax: 0.12 after block) and a significant decrease in
tiffness (measured in passive condition) of 17% on average. The dominant
ffect of lidocaine is on the Ia afferent fibers but also by an action on the
pindle sensitivity and resting muscle tone. The lidocaine block reproduces
he effect of selective tibial neurotomy on all clinical and neuromechanical
arameters.
onclusion.– We validated a complete neuromechanical protocol to study the
pastic equinus foot in which it would be interesting to add the gait analysis
aboratory. We show the stable long-term effectiveness of selective tibial neuro-
omy in the treatment of the spastic equinus foot and finally the predictivity of
he lidocaine block.
oi:10.1016/j.rehab.2011.07.561
O16-003–EN
valuation of the relationships between spasticity, motor
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bjectives.– This study aims at evaluating the relationships between motor defi-
it, spasticity and kinematics of the upper limb in hemiparetic patients during
eaching movements.
he principal aim is to determine whether the velocity of reaching movements
nvolving elbow extension is mainly determined by spasticity or the motor deficit.
he secondary aim is to quantify the relationship between elbow flexor and
xtensor torque and elbow angular position relative to angular velocity. The
ong-term aim is to evaluate which of these variables are the most predictive of
unctional capacity.
ethods.– Twelve patients with spastic hemiparesis, troublesome elbow flexor
pasticity and active range of elbow extension of at least 30◦ will be included.
atients with bilateral brain damage, severe apraxia and/or aphasia, cerebellar
yndrome, or another cause of stiff elbow will be excluded.
valuations consist of a physical examination including use of scales (Fugl-
eyer, Action Research Arm Test, Motor Activity Log). Activation and control
f the elbow flexors and extensors will be evaluated using an isokinetic dyna-
ometer that records torque produced during passive stretch and concentric
sokinetic torque at different velocities as well as isometric torque.
he kinematics of reaching movements will be evaluated using three-
imensional motion analysis. Spontaneous and maximal reaching velocity to
wo targets (65% and 90% of the upper limb length, in line with the shoulder)
ill be assessed. Surface electromyography will be recorded for each of thenstrumented evaluations.
esults.– The relationship between elbow extension angular velocity in the rea-
hing task, and stretch reflex threshold and flexor/extensor torque during passive
nd active isokinetic movements will be analysed using correlations.
S
S
bation Medicine 54S (2011) e131–e147
he relationship between flexor and extensor torque produced during concentric
sokinetic movements, angular position and elbow extension angular velocity
ill also be analyzed.
iscussion.– This preliminary work should give indications regarding the control
f voluntary movements in hemiparetic patients. The collection of quantified
ata will assist in the appropriate adaptation of rehabilitation protocols, taking
nto account patient characteristics and should also help to specify indications
or different rehabilitation techniques (physical, neuro-modulating and use of
otulinum toxin or other pharmacological treatments).
oi:10.1016/j.rehab.2011.07.562
O16-004–EN
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ntroduction.– Hemiplegia is often associated with a pattern of upper limb spas-
icity with adduction, internal rotation and flexion of the shoulder, pronation,
exion of the elbow, wrist and fingers flexion making it difficult to identify
nd to treat flexor digitorum superficialis and profundis with botulinum toxin.
he progress of high-frequency ultrasound probes has for many years allowed
precise location of osteo-articular structures.
bjectives.– Our study aimed at assessing the feasibility of tracking flexor
igitorum profundus and superficialis by ultrasound system in stroke patients.
aterial and method.– Ten post-stroke patients with an Ashworth modified
core of at least two on the main upper limb muscles and with the upper limb
pontaneously placed with elbow flexion, pronation of the forearm and finger
exion were included. An ultrasound probe with a high frequency of 10 MHz
as used for the ultrasonographic tracking.
racking sonography was performed in each patient’s healthy side, in the ana-
omical position and then flexion and pronation of the elbow and finger flexion.
hen, each patient underwent an ultrasound tracking in the hemiplegic side of
he flexor digitorum superficialis and the flexor digitorum profundus.
esults.– The first set of ultrasounds allowed us to establish key benchmarks.
hus, from an axial section enabling to identify the biceps the brachial artery,
hen the pronator teres. The flexor digitorum superficialis was viewed from
umerus, ulna and radius insertion. By moving the probe down, the flexor
igitorum profundis could be identified. These two muscles, as well as the
ccompanying noble structures can be tracked until their distal end.
or patients with moderate spasticity, this technique allows a precise anatomical
ocation of the flexor superficialis and profundis muscles. However, for patients
ith high spasticity this technique requires an assistant’s help.
iscussion et conclusion.– This identification technique with ultrasound system
s simple and allows us to consider highly selective and safe injections of finger
exor muscles. Patients with neuro-orthopedic deformities and therefore difficult
ccess for botulinum toxin injections could benefit from this technique.
oi:10.1016/j.rehab.2011.07.563
O16-005–EN
oal setting and attainment pertaining to upper and lower
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opic.– New techniques of rehabilitation and assessment (TBC).
bjectives.– To describe rehabilitation goals and attainment of upper (UL) and
ower limb (LL) function in focal PSS patients, using goal attainment scaling.
ethods.– Subjects were randomised to Botox® (BoNT-A) + standard care (SC)
r placebo + SC for up to 2 treatment cycles, followed by an open-label phase
p to a total of 52 weeks. Eligible patients were BoNT-A naïve, demonstrated
reserved function in the limb to be treated, and were considered likely to benefit
rom the intervention. For each patient, a principal active functional goal was
efined as well as a secondary active or passive goal and the principal goal
ttainment was measured at the end of the randomised period.
esults.– The intent-to-treat population comprised 273 patients recruited in
anada, Germany, Sweden and the UK (59% male; mean age: 61.5 years; median
ime since stroke: 22.8 months). In total, 165 patients had a principal or secondary
ctive goal concerning UL function (respectively 116 and 49), 222 patients had
ither a principal or secondary active goal concerning LL function (respectively
57 and 65), and 158 patients had a secondary passive goal.
or patients with an active goal pertained to UL function, the main goal categories
ere: ability to grasp and hold objects with either gross or fine movements
31.5%), feeding (23.6%), dressing (16.4%), and improved upper limb range
f movement (12.7%). For those patients whose principal active goal pertained
o LL function, most were associated with walking/mobility (89.2%) including
mprovements in speed, distance, gait and ability to climb stairs.
ctive goals pertaining to UL were achieved by 39.5% of patients receiving
oNT-A + SC and 30.7% of patients receiving placebo + SC and active LL
oals were achieved by 41.9% of patients receiving BoNT-A + SC and 45.1%
f patients receiving placebo + SC. Secondary passive goals were achieved by
0.6% of the patients receiving BoNT-A + SC and 38.6% of patients receiving
lacebo + SC.
onclusion.– More patients treated with Botox® + SC achieved their UL active
oals and passive goals compared to placebo + SC.
oi:10.1016/j.rehab.2011.07.564
O16-006–EN
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bjective.– The study asked whether an early BTX-A injection in sub-acute
troke patients may prevent a disabling finger flexor spasticity six months later.
esign.– A single-blind, randomized pilot study.
etting.– In-patient rehabilitation centre.
ubjects.– Eighteen stroke patients, interval 4–6 weeks, non-functional upper
imb (UL), Fugl-Meyer UL score (FM, 0–66) < 20, beginning finger flexor spas-
icity, randomly allocated to group A or B.
nterventions.– In A-patients 150 units BTX-A (Xeomin) injected into the deep
nd superficial finger (100 units) and wrist flexors (50 units), no injection in
-patients. Comprehensive rehabilitation in both groups.
ain measures.– Primary variable was the modified Ashworth score (AS, 0–5)
f the finger flexors, secondary the whole UL tonus with the REPAS, the UL
otor control with the FM, and a disability scale, blindly assessed at T0 (begin),
1 (4 weeks) and T6 (6 months).
esults.– Homogeneous groups at T0. Significantly less finger flexor tonus in
he BTX-A group at T1 and T6, the mean (SD) AS scores in group A (B) were:
.7 ± 0.5, (1.6 ± 0.5) at T0; 0.4 ± 0.5 (1.9 ± 0.7) at T1; and 1.4 ± 0.7 (2,4 ± 0.9)
a
a
R
bation Medicine 54S (2011) e131–e147 e137
t T6. Among the secondary, the disability score, namely the items pain and
assive nail trimming, was less in group A at T1 and T6.
onclusions.– The pilot character prohibits any conclusions, but the results indi-
ate a prohibitive effect of an early BTX-A injection on finger flexor spasticity
ix months later. By minimizing involuntary muscle activity, the fingers were
eld in a less fixed position, which may have hindered contractures, usually
apidly developing.
oi:10.1016/j.rehab.2011.07.565
O16-007–EN
alidation study of subjective spasticity questionnaire
. Petropoulou
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bjective.– To test the validity and reliability of a subjective questionnaire
or evaluation of spasticity during daytime, sleep and activities of daily living
ADL).
ubjects and methods.– Our sample consisted of 50 subjects (30 male) with
ean age 48.2 ± 15.3 years (ranging from 21 to 84 years). The questionnaire
as constructed based on the functional classification of disability according to
HO. (2001) and it is self-administered. It consists of 12 domains (Likert scale)
or evaluation of the effect of pain, involuntary movement and spasticity on ADL
uch sleep quality, hygiene, routine activities, social life, driving, orthosis wear
nd gait. Reliability was tested via Cronbach’s  coefficient. The item discrimi-
ant validity test was performed according to the severity of complaints based
n clinical evaluation of spasticity via modified Asworth scale. The construct
alidity was tested via item-scale correlations.
esults.– More than half of the patients reported that spasticity, accompa-
ying pain and involuntary movements were getting more intense during night.
edium to severe spasticity, accompanying pain and involuntary movements
ere reported by 80.4%, 52.9% and 60% of the subjects, respectively. Most of
he complaints were noted during walking. Internal consistency was measured
y Cronbach’s , which was found 0.96 for questions concerning pain, 0.98
or questions concerning involuntary movements and 0.97 for spasticity. The
ore severe the clinical grade of spasticity, the more troublesome complaints
ere reported by the patients in a number of questions. The Pearson correlation
oefficients ranged mostly from medium (r > 0.4) to high (r > 0.6), indicating
edium to high reproducible scales, respectively.
onclusion.– The questionnaire is a promising, new instrument for evaluation of
he subjective feeling of spasticity during night and ADL. It comes up forward
o fill in the gap in the field of spasticity and it is useful for recording the
ffectiveness of spasticity treatment outcome and rehabilitation program.
oi:10.1016/j.rehab.2011.07.566
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oot in adults: Effect on gait parameters. Comparative
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troke is the leading cause of disability for adults in France. After stroke, equi-
ovarus foot is the main cause of gait abnormalities. The efficiency of botulinum
oxin in decreasing spasticity has been demonstrated but the effects on gait para-
eters (gait velocity. . .) are still conflicting. The purpose of this study was to
valuate the effects of an injection of botulinum toxin type A, compared with
lacebo, on gait parameters.
ethods.– This was a multicenter, randomised, double-blind, versus placebo
tudy. To be included, patients had to suffer from a hemiplegia with an equi-
ovarus foot due to stroke. A medical examination (physical examination, gait
nalysis using a GAITRite® system. . .) was performed before and 4 to 6 weeks
fter the injection.
esults.– We included 49 patients, randomised in two groups: treatment with
otulinum toxin type A (n = 23) and placebo (n = 26). No significant difference
